RESUMEN
Here, we describe a spontaneous outbreak of strongyloidiasis (Strongyloides papillosus) in sheep in Uruguay. In a flock of 150 lambs, 60 animals became ill and 12 died within 3 weeks. Affected animals showed weakness, weight loss, enophthalmos and, in some cases, sudden death. Postmortem examination revealed muscle atrophy, dehydration, and small intestines with a foamy and liquid content. Histological examination of the duodenum and the jejunum showed a thick mucosa with severe villous atrophy, mononuclear mixed infiltrate in the lamina propria, and a large number of nematodes embedded in the mucosa, with numerous granulomas in the lamina propia. Small intestinal content analysis showed a total of 13,200 female nematodes in the duodenum and 2000 in the jejunum, identified as Strongyloides papillosus (Strongyloididae). This parasite has long been considered to behave as a commensal parasite or at least to cause significant disease only when present in large numbers. This report shows that Strongyloides papillosus can be highly pathogenic in sheep.
Asunto(s)
Enfermedades de las Ovejas , Estrongiloidiasis , Animales , Heces/parasitología , Femenino , Ovinos , Enfermedades de las Ovejas/parasitología , Strongyloides , Estrongiloidiasis/epidemiología , Estrongiloidiasis/veterinaria , Uruguay/epidemiologíaRESUMEN
Uruguay is a leading exporter of bovine meat and dairy products, and cattle production is one of the principal economic backbones in this country. A main clinical problem faced by livestock farmers is neonatal calf diarrhea (NCD); however, causes of NCD have not been extensively studied in Uruguay. Bovine norovirus (BoNoV) has been proposed as one of the possible etiologies of NCD as experimentally infected calves developed diarrhea and enteropathy, although limited information is available from field surveys. The aims of this study were to determine the frequency of infection, to investigate possible risk factors, and to determine the molecular diversity of BoNoV in Uruguay. A total of 761 samples of feces or intestinal contents from dairy and beef calves were analyzed through RT-qPCR. The overall frequency of detection of BoNoV was 66.1% with higher frequency in dairy (70.5%) than beef (15.9%) calves (p < 0.01). BoNoV was detected similarly in diarrheic (78.8%) and non-diarrheic (76.2%) dairy calves (p = 0.50). Calves ≤2 weeks of age (84%) were infected more often than older (62.7%) calves (p < 0.01). Phylogenetic analysis confirmed the presence of GIII.1 and GIII.2 genotypes. In addition, we reported the circulation of recombinant strains and the detection of a strain with the recently described novel VP1 genotype. This study represents the first report describing the circulation, the associated risk factors, and the molecular diversity of BoNoV in Uruguay.
Asunto(s)
Infecciones por Caliciviridae/veterinaria , Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/virología , Variación Genética , Norovirus/clasificación , Norovirus/genética , Animales , Bovinos , Diarrea/veterinaria , Susceptibilidad a Enfermedades , Genotipo , Filogenia , Factores de Riesgo , Uruguay/epidemiologíaRESUMEN
Uruguay is one of the main exporters of beef and dairy products, and cattle production is one of the main economic sectors in this country. Rotavirus A (RVA) is the main pathogen associated with neonatal calf diarrhea (NCD), a syndrome that leads to significant economic losses to the livestock industry. The aims of this study are to determine the frequency of RVA infections, and to analyze the genetic diversity of RVA strains in calves in Uruguay. A total of 833 samples from dairy and beef calves were analyzed through RT-qPCR and sequencing. RVA was detected in 57.0% of the samples. The frequency of detection was significantly higher in dairy (59.5%) than beef (28.4%) calves (p < 0.001), while it did not differ significantly among calves born in herds that were vaccinated (64.0%) or not vaccinated (66.7%) against NCD. The frequency of RVA detection and the viral load were significantly higher in samples from diarrheic (72.1%, 7.99 log10 genome copies/mL of feces) than non-diarrheic (59.9%, 7.35 log10 genome copies/mL of feces) calves (p < 0.005 and p = 0.007, respectively). The observed G-types (VP7) were G6 (77.6%), G10 (20.7%), and G24 (1.7%), while the P-types were P[5] (28.4%), P[11] (70.7%), and P[33] (0.9%). The G-type and P-type combinations were G6P[11] (40.4%), G6P[5] (38.6%), G10P[11] (19.3%), and the uncommon genotype G24P[33] (1.8%). VP6 and NSP1-5 genotyping were performed to better characterize some strains. The phylogenetic analyses suggested interspecies transmission, including transmission between animals and humans.
RESUMEN
Gastrointestinal nematode infections, including Haemonchus contortus, are one of the main causes of economic losses to ovine farmers worldwide. In order to contribute to the control of nematode infections and avoid parasite spreading we generated divergent resistant and susceptible sheep breeds and evaluated the adaptive immunity of these animals developed upon experimental infection against H. contortus. The selection of resistant or susceptible animals from the Corriedale Breed has been based on Expected Progeny Differences for faecal egg counts per gram. Furthermore, animals from the resistant Corriedale line were inseminated with imported semen from Australian Rylington Merino rams. Thus, the objective of this work was to analyze the adaptive immune response in both susceptible and resistant obtained lambs. Our results indicate that there is a potent parasite-specific local and systemic immune response in resistant animals and that although susceptible lambs can produce high levels of IgA antibodies during the infection, their antibody response is delayed which, together with an impaired specific-Th2 response, does not contribute to initial parasite elimination. Our results shed light into the immune mechanisms that mediate resistance to H. contortus and could constitute important assets to sheep farmers, not only as a means to detect resistance, but also to enhance the efficiency of selection in stud flocks.
Asunto(s)
Haemonchus/patogenicidad , Inmunidad Adaptativa/fisiología , Animales , Formación de Anticuerpos/fisiología , Femenino , Haemonchus/inmunología , Inmunoglobulina A/metabolismo , Masculino , Ovinos , Enfermedades de las Ovejas/inmunología , Enfermedades de las Ovejas/microbiología , Células Th2/metabolismoRESUMEN
Bovine coronavirus (BCoV) is a recognized cause of severe neonatal calf diarrhea, with a negative impact on animal welfare, leading to economic losses to the livestock industry. Cattle production is one of the most important economic sectors in Uruguay. The aim of this study was to determine the frequency of BCoV infections and their genetic diversity in Uruguayan calves and to describe the evolutionary history of the virus in South America. The overall detection rate of BCoV in Uruguay was 7.8% (64/824): 7.7% (60/782) in dairy cattle and 9.5% (4/42) in beef cattle. The detection rate of BCoV in samples from deceased and live calves was 10.0% (6/60) and 7.6% (58/763), respectively. Interestingly, there was a lower frequency of BCoV detection in calves born to vaccinated dams (3.3%, 8/240) than in calves born to unvaccinated dams (12.2%, 32/263) (OR: 4.02, 95%CI: 1.81-8.90; p = 0.00026). The frequency of BCoV detection was higher in colder months (11.8%, 44/373) than in warmer months (1.5%, 3/206) (OR: 9.05, 95%CI: 2.77-29.53, p = 0.000013). Uruguayan strains grouped together in two different lineages: one with Argentinean strains and the other with Brazilian strains. Both BCoV lineages were estimated to have entered Uruguay in 2013: one of them from Brazil (95%HPD interval: 2011-2014) and the other from Argentina (95%HPD interval: 2010-2014). The lineages differed by four amino acid changes, and both were divergent from the Mebus reference strain. Surveillance should be maintained to detect possible emerging strains that can clearly diverge at the antigenic level from vaccine strains.
Asunto(s)
Antígenos Virales/genética , Enfermedades de los Bovinos/epidemiología , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/veterinaria , Coronavirus Bovino/aislamiento & purificación , Animales , Antígenos Virales/inmunología , Argentina/epidemiología , Brasil/epidemiología , Bovinos , Enfermedades de los Bovinos/prevención & control , Enfermedades de los Bovinos/virología , Infecciones por Coronavirus/prevención & control , Coronavirus Bovino/genética , ADN Viral/genética , Disentería/epidemiología , Disentería/veterinaria , Disentería/virología , Variación Genética/genética , Uruguay/epidemiología , VacunaciónRESUMEN
The goals of the current trial were (a) to characterize the plasma disposition kinetics of levamisole (LEV), albendazole (ABZ) and ivermectin (IVM), each administered either alone (single active ingredient) or as a combined formulation to lambs; (b) to compare the clinical anthelmintic efficacy of the same drugs given either separately or co-administered to lambs infected with resistant nematodes. Fifty Corriedale lambs naturally infected with multiple resistant gastrointestinal nematodes were involved in the following experimental trials: (a) "Pharmacokinetic trial": the animals were allocated into five groups (n=10 each) and intraruminally treated with either LEV (8 mg/kg), ABZ (5mg/kg), IVM (0.2mg/kg), or with a LEV+ABZ+IVM combined formulation, where each active ingredient was administered at the same dose. Blood samples were collected over 15 days post-treatment and drug plasma concentrations measured by HPLC. (b) "Efficacy trial": the same treated groups plus an untreated control group were used to assess the comparative anthelmintic efficacy by the faecal egg count reduction test (FECRT). Although the overall LEV disposition kinetics was unaffected, significantly lower (61%) ABZ-sulphoxide and higher (71%) IVM systemic availabilities were obtained after administration of the combined formulation in comparison to those obtained after treatment with each drug alone. A multiple drug resistance situation was observed for Haemonchus spp. The observed efficacies were 52% (LEV), 72% (ABZ), 80% (IVM) and 87% (triple combined formulation). The results reported here contribute to the pharmaco-therapeutic knowledge on drug combinations. This type of research is crucial before further development of combined anthelmintic preparations reaches the market to deal with resistant nematode control. The co-administration of LEV+ABZ+IVM did not result in a significant advantageous anthelmintic effect compared to the treatment with IVM alone. The simultaneous/combined administration of LEV, ABZ and IVM may account for a drug-drug pharmacological interaction in infected lambs. The pharmacokinetic interaction accounted for a reduced ABZ-sulphoxide and enhanced IVM systemic exposure following the combined treatment.
Asunto(s)
Antihelmínticos/administración & dosificación , Antihelmínticos/farmacocinética , Infecciones por Nematodos/veterinaria , Enfermedades de las Ovejas/tratamiento farmacológico , Albendazol/administración & dosificación , Albendazol/análogos & derivados , Albendazol/sangre , Albendazol/farmacocinética , Animales , Antihelmínticos/sangre , Antihelmínticos/farmacología , Área Bajo la Curva , Interacciones Farmacológicas , Resistencia a Medicamentos/efectos de los fármacos , Heces/parasitología , Femenino , Ivermectina/administración & dosificación , Ivermectina/sangre , Ivermectina/farmacología , Levamisol/administración & dosificación , Levamisol/sangre , Levamisol/farmacocinética , Masculino , Nematodos/efectos de los fármacos , Infecciones por Nematodos/tratamiento farmacológico , Recuento de Huevos de Parásitos/veterinaria , Ovinos , TiempoRESUMEN
BACKGROUND: Several oral ivermectin (IVM) formulations for use in sheep are available in the pharmaceutical veterinary market in different countries. All of them are indicated at the same dose rate to treat the gastrointestinal nematodes. However, there is a lack of information on the relative systemic exposure (plasma bioavailability) and clinical efficacy among oral formulations routinely used in sheep. The main goal of the work reported here was to perform a pharmaco-parasitological assessment of three different IVM oral formulations in lambs infected with multiple resistant gastrointestinal nematodes. The comparative drug systemic exposure (IVM plasma concentrations) and nematodicidal efficacies (clinical efficacy) in lambs were determined for a reference (RF) and two different test (T1, T2) IVM oral formulations. One hundred and fifty six (n= 156) healthy Corriedale lambs, naturally infected with multiple resistant gastrointestinal nematodes were allocated into four experimental groups (n=39). Animals in each group received treatment (200 µg/kg) with either the RF, one of the test IVM formulations or were kept as untreated control. Blood samples were collected over 15 days post-treatment (n=8). The IVM plasma concentrations were measured by high performance liquid chromatography with fluorescence detection. The faecal nematode egg count reduction test (FECRT) (n=39) and evaluation of the clinical efficacy were performed at day 14 post-treatment (n=6), where a predominance of IVM highly resistant nematodes was observed. RESULTS AND CONCLUSIONS: Neither the overall kinetic behaviour nor the IVM systemic exposure differed among all the tested oral formulations. Equivalent efficacy results were obtained for the different preparations, with an evident therapeutic failure to control Haemonchus spp. and Teladorsagia circumcincta, which correlates with a high degree of nematode resistance to IVM.
Asunto(s)
Antinematodos/farmacocinética , Ivermectina/farmacocinética , Administración Oral , Animales , Animales Recién Nacidos , Antinematodos/administración & dosificación , Antinematodos/uso terapéutico , Disponibilidad Biológica , Heces/parasitología , Femenino , Ivermectina/administración & dosificación , Ivermectina/uso terapéutico , Masculino , Infecciones por Nematodos/tratamiento farmacológico , Infecciones por Nematodos/parasitología , Infecciones por Nematodos/veterinaria , Recuento de Huevos de Parásitos/veterinaria , Ovinos , Enfermedades de las Ovejas/tratamiento farmacológico , Enfermedades de las Ovejas/parasitología , Resultado del TratamientoRESUMEN
The efficacy of the novel anthelmintic, monepantel (an amino-acetonitrile derivative), was investigated in sheep naturally infected with gastrointestinal nematodes in five studies in Argentina, Brazil, and Uruguay. Monepantel, administered at 2.5 mg/kg liveweight, was highly effective (>99.7%) against Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta, Trichostrongylus axei, Trichostrongylus colubriformis, Cooperia curticei, Cooperia mcmasteri, Cooperia oncophora, Cooperia pectinata, Cooperia punctata, and Nematodirus spathiger, including strains resistant to the older broad-spectrum anthelmintics. Efficacy against C. mcmasteri, C. pectinata, and C. punctata is documented for the first time. The treatment with monepantel was well tolerated by the sheep.
Asunto(s)
Aminoacetonitrilo/análogos & derivados , Antinematodos/uso terapéutico , Enfermedades Gastrointestinales/veterinaria , Infecciones por Nematodos/veterinaria , Enfermedades de las Ovejas/tratamiento farmacológico , Aminoacetonitrilo/administración & dosificación , Aminoacetonitrilo/efectos adversos , Aminoacetonitrilo/uso terapéutico , Animales , Antinematodos/administración & dosificación , Antinematodos/efectos adversos , Argentina , Brasil , Heces/parasitología , Femenino , Enfermedades Gastrointestinales/tratamiento farmacológico , Masculino , Infecciones por Nematodos/tratamiento farmacológico , Recuento de Huevos de Parásitos , Ovinos , Enfermedades de las Ovejas/parasitología , Resultado del Tratamiento , UruguayRESUMEN
Se determinó la presencia de anticuerpos contra Toxoplasma gondii, antes y después de la gestación, con la reacción de aglutinación directa para toxoplasmosis (AD), en 1613 ovejas de 18 establecimientos de diferentes Departamentos del Uruguay, de 1992 a 1994. La prevalencia total de la infección ascendió de 28,7 por ciento antes de la gestación a 38,5 por ciento, luego de la misma. La incidencia fue, por lo tanto de 9,8 por ciento. Las pérdidas debidas a la infección toxoplásmica durante la gestación se estimaron teóricamente con una fórmula que contempla el nivel de incidencia así como algunos factores de la patogénesis de la enfermedad en el ovino. Sobre esta base, de 1,4 a 3,9 por ciento del total de las ovejas investigadas pudieron haber perdido sus corderos debido a la toxoplasmosis. Esto representa una pérdida económica anual para la industria ovina en el Uruguay de 1,9 a 5,2 millones de dólares americanos. En la estación de parición de 1993, de 562 ovejas y borregas que fueron servidas en uno de los establecimientos. 154 tuvieron corderos y 125 abortaron. Se aisló Toxoplasma mediante bioensayos, a partir de los fetos abortados. Veintiocho sueros de ovejas que abortaron presentaron títulos de 1:16.384 o mayores con el test de AD. Se apreciaron puntos blancos de necrosis del tamaño de la cabeza de un alfiler sobre la superficie de los cotiledones placentarios de las ovejas que abortaron. Los hallazgos histopatológicos fueron necrosis y calcificación de las vellosidades cotiledonarias y encefalitis, hepatitis y neumonía. Seis meses luego de los abortos, 55,6 por ciento de 300 ovejas presentaron títulos de 1:1.024 o mayores, reflejando la extensión de la infección. Se detectaron abortos toxoplásmicos en otros establecimientos, el mismo año. Se destaca la situación de subdiagnóstico de la toxoplasmosis ovina, al quedar enmascarada por otras causas de pérdidas de corderos más extensivos, salvo que adopte la magnitud inusual del caso relatado